Ophthalmic drug compositions
US12390363B2 · kind B2 · utility
0Cited by
4References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2022 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Jul 13, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/0612
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a drug composition comprising particles comprising a biodegradable or bioerodable polymer and a drug, a soluble, biodegradable or bioerodible excipient, a bulking agent and a reconstitution aid. The invention also provides a pharmaceutical formulation and a unit dosage form of the pharmaceutical formulation. The invention provides methods of treatment of a disease or condition accordingly. The invention also provides a drug composition for use in a cannulation device.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.